A double blind randomised placebo controlled clinical trial testing the effectiveness of a Chinese herbal medicine extract formulation for constipation-predominant Irritable Bowel Syndrome.

This research project will test whether Chinese herbal medicine is useful for treating constipation predominant Irritable Bowel Syndrome (C-IBS). C-IBS has multiple symptoms, including abdominal pain, bloating, constipation and changed bowel habits. The Chinese herbal formulation being tested has been designed to address the multiple symptoms of C-IBS.
This dataset contains PDF files of particpant information sheets, consent forms and Case Report Forms (CRFs).
The data relates to clinical trial ACTRN12609000558224 Clinical and physiological evaluation of a Chinese herbal medicine for constipation-predominant Irritable Bowel Syndrome (C-IBS Trial).
To discuss this trial, please contact the NICM Health Research Institute [e-mail].

本研究项目旨在验证中药对以便秘为主型肠易激综合征（constipation predominant Irritable Bowel Syndrome, C-IBS）的治疗效用。以便秘为主型肠易激综合征存在多种临床症状，包括腹痛、腹胀、便秘及排便习惯改变。本次受试的中药复方专为缓解C-IBS的多类症状而研发。
本数据集包含受试者信息表、知情同意书及病例报告表（Case Report Forms, CRFs）的PDF文件。
该数据集关联临床试验ACTRN12609000558224《中药治疗以便秘为主型肠易激综合征的临床与生理学评估》（C-IBS试验）。
如需咨询该试验相关事宜，请联系NICM健康研究院（NICM Health Research Institute），邮箱：[e-mail]。